Login / Signup

Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD).

James F DonohueEdward KerwinSanjay SethiBrett HaumannSrikanth PendyalaLorna DeanChris N BarnesEdmund J MoranGlenn D Crater
Published in: Respiratory research (2019)
NCT02518139 ; Registered 5 August 2015.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • high intensity
  • early onset
  • gestational age
  • drug induced